CUSIP: 83578Q209
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,849,011
-
Share change
-
-4,371,378
-
Total reported value
-
$998,000
-
Price per share
-
$0.54
-
Number of holders
-
11
-
Value change
-
-$14,148,828
-
Number of buys
-
6
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP 83578Q209?
CUSIP 83578Q209 identifies SPHS - SOPHIRIS BIO INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 83578Q209:
Institutional Holders of SOPHIRIS BIO INC - COM NEW (SPHS) as of Q4 2014
As of 31 Dec 2014,
SOPHIRIS BIO INC - COM NEW (SPHS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,849,011 shares.
The largest 10 holders included
BVF INC/IL, Gruss Capital Management LP, Palo Alto Investors, LLC, KCG Holdings, Inc., Bank of New York Mellon Corp, ROYAL BANK OF CANADA, UBS Group AG, CITIGROUP INC, BlackRock Investment Management, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.